Previous close | 0.4000 |
Open | 0.4000 |
Bid | 0.0000 |
Ask | 0.7500 |
Strike | 13.00 |
Expiry date | 2025-01-17 |
Day's range | 0.4000 - 0.4000 |
Contract range | N/A |
Volume | |
Open interest | 24 |
Exelixis (EXEL) misses on earnings and sales in the first quarter. Its shares are trading down in response to the results.
Exelixis reports robust financial performance and outlines key strategies in oncology asset development and commercial expansion.